DrugPatentWatch Database Preview
Details for Patent: 10,292,990
Email this page to a colleague
See Plans and PricingWhich drugs does patent 10,292,990 protect, and when does it expire?
Patent 10,292,990 protects YONSA and is included in one NDA.
This patent has thirty-seven patent family members in twenty-one countries.
Summary for Patent: 10,292,990
| Title: | Abiraterone steroid formulation |
| Abstract: | A nanoparticulate composition of abiraterone acetate that allows treatment at a lower dose than convention abiraterone acetate formulations is described as in a method of treating prostate cancer by administering the composition together with a glucocorticoid. |
| Inventor(s): | Nemeth; Paul (Philadelphia, PA), Callahan; Matt (Penn Valley, PA), Bosch; H. William (Bryn Mawr, PA), Norret; Marck (Darlington, AU) |
| Assignee: | SUN PHARMA GLOBAL FZE (Sharjah, AE) |
| Application Number: | 15/345,410 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 10,292,990
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Global | YONSA | abiraterone acetate | TABLET;ORAL | 210308-001 | May 22, 2018 | RX | Yes | Yes | Start Trial | Start Trial | USE IN COMBINATION WITH METHYLPREDNISOLONE FOR THE TREATMENT OF PATIENTS WITH PROSTATE CANCER | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,292,990
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 095480 | Start Trial | |||
| Australia | 2014232508 | Start Trial | |||
| Australia | 2015317466 | Start Trial | |||
| Australia | 2018241103 | Start Trial | |||
| Brazil | 112015023629 | Start Trial | |||
| Brazil | 112017003219 | Start Trial | |||
| Canada | 2907415 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
